Restifo NP - Search Results

1

Programming CD8+ T cells for effective immunotherapy.

Hinrichs CS, Gattinoni L, Restifo NP. Hinrichs CS, et al. Among authors: restifo np. Curr Opin Immunol. 2006 Jun;18(3):363-70. doi: 10.1016/j.coi.2006.03.009. Epub 2006 Apr 17. Curr Opin Immunol. 2006. PMID: 16616471 Free PMC article. Review.

2

A nonimmunogenic sarcoma transduced with the cDNA for interferon gamma elicits CD8+ T cells against the wild-type tumor: correlation with antigen presentation capability.

Restifo NP, Spiess PJ, Karp SE, Mulé JJ, Rosenberg SA. Restifo NP, et al. J Exp Med. 1992 Jun 1;175(6):1423-31. doi: 10.1084/jem.175.6.1423. J Exp Med. 1992. PMID: 1588273 Free PMC article.

3

Synthetic oligonucleotide expressed by a recombinant vaccinia virus elicits therapeutic CTL.

Irvine KR, McCabe BJ, Rosenberg SA, Restifo NP. Irvine KR, et al. Among authors: restifo np. J Immunol. 1995 May 1;154(9):4651-7. J Immunol. 1995. PMID: 7722317 Free PMC article.

4

Active immunotherapy of cancer with a nonreplicating recombinant fowlpox virus encoding a model tumor-associated antigen.

Wang M, Bronte V, Chen PW, Gritz L, Panicali D, Rosenberg SA, Restifo NP. Wang M, et al. Among authors: restifo np. J Immunol. 1995 May 1;154(9):4685-92. J Immunol. 1995. PMID: 7722321 Free PMC article.

5

Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.

Irvine KR, Rao JB, Rosenberg SA, Restifo NP. Irvine KR, et al. Among authors: restifo np. J Immunol. 1996 Jan 1;156(1):238-45. J Immunol. 1996. PMID: 8598468 Free PMC article.

6

IL-12 is an effective adjuvant to recombinant vaccinia virus-based tumor vaccines: enhancement by simultaneous B7-1 expression.

Rao JB, Chamberlain RS, Bronte V, Carroll MW, Irvine KR, Moss B, Rosenberg SA, Restifo NP. Rao JB, et al. Among authors: restifo np. J Immunol. 1996 May 1;156(9):3357-65. J Immunol. 1996. PMID: 8617961 Free PMC article.

7

The new vaccines: building viruses that elicit antitumor immunity.

Restifo NP. Restifo NP. Curr Opin Immunol. 1996 Oct;8(5):658-63. doi: 10.1016/s0952-7915(96)80082-3. Curr Opin Immunol. 1996. PMID: 8902391 Free PMC article. Review.

8

Apoptotic death of CD8+ T lymphocytes after immunization: induction of a suppressive population of Mac-1+/Gr-1+ cells.

Bronte V, Wang M, Overwijk WW, Surman DR, Pericle F, Rosenberg SA, Restifo NP. Bronte V, et al. Among authors: restifo np. J Immunol. 1998 Nov 15;161(10):5313-20. J Immunol. 1998. PMID: 9820504 Free PMC article.

9

Developing recombinant and synthetic vaccines for the treatment of melanoma.

Restifo NP, Rosenberg SA. Restifo NP, et al. Curr Opin Oncol. 1999 Jan;11(1):50-7. doi: 10.1097/00001622-199901000-00012. Curr Opin Oncol. 1999. PMID: 9914879 Free PMC article. Review.

10

Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition.

Zaks TZ, Chappell DB, Rosenberg SA, Restifo NP. Zaks TZ, et al. Among authors: restifo np. J Immunol. 1999 Mar 15;162(6):3273-9. J Immunol. 1999. PMID: 10092779 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

356 results

Search Page

Filters